Alector, Inc

ALECNASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

111.7M

on 2026-06-30, from 96.4M on 2024-03-31 10-Q ↗

Newest

$400.0M

S-3 of 2026-03-12. 1 prospectus supplement filed under it since. S-3 ↗

$125.0M

TD Securities (USA), agreement of 2026-05-07. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-06 is not read yet.

Cash

4.4 quarters

$172.8M on 2026-06-30 ÷ $39.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 2 of its filings are not read yet.